
New Leaf Venture Partners is a venture capital firm focused exclusively on healthcare technology, investing across biopharmaceuticals, medical devices, molecular diagnostics, and healthcare IT. Founded in 2005 as a healthcare spinoff from the Sprout Group, the firm partners with companies from early-stage through public offerings.
Deal activity increased 50% year-over-year (3 deals in the last 12 months). Average disclosed round size is $48.4M (across 92 rounds with reported amounts).
Portfolio
66
Fund Size
—
Top Stage
Series C
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
92 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Unknown | $13M | Jan 2026 | |
| Series C | $183M | Oct 2025 | |
| EElectra Therapeutics | Series C | $183M | Oct 2025 |
| Series C | $200M | Feb 2025 | |
| Series D | $125M | Jan 2025 | |
| EElectra Therapeutics | Series B | $84M | Jan 2025 |
| Series A | $100M | Jan 2025 | |
| Series C | $106M | Dec 2024 | |
| Seed | $2.3M | Apr 2024 | |
| Series C | $20M | Mar 2024 | |
| Series C | $20M | Jan 2024 | |
| Series C | $52M | Jan 2023 | |
| Series B | $29M | Aug 2022 | |
| EElectra Therapeutics | Series B | $84M | Feb 2022 |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
| AAkili, Inc. | Series D | $110.0M | May 2021 |
| AAkili, Inc. | Series D | $110M | Jan 2021 |
| Series B | $50M | Sep 2019 | |
| Series A | $11M | Jan 2019 | |
| RRenovacor | Series A | $11M | Jan 2019 |
| Series A | $11M | Jan 2019 | |
| Series C | $56M | Jan 2019 | |
| Series C | $44M | Aug 2018 | |
| Series A | $37M | Apr 2018 | |
| Series C | $55M | Apr 2018 |
Page 1 of 4
Top Co-Investors
OrbiMed23 shared
Redmile Group10 shared
Pivotal Life Sciences9 shared
RA Capital Management8 shared
Canaan Partners8 shared
Morgenthaler Ventures8 shared
Frazier Healthcare Partners7 shared
SR One7 shared
Sanofi Ventures6 shared
Foresite Capital6 shared
Sofinnova Partners5 shared
New Enterprise Associates5 shared
Pappas Capital5 shared
Novartis Venture Fund5 shared
Scale Venture Partners4 shared
Sands Capital4 shared
Blue Owl Capital4 shared
Cormorant Asset Management4 shared
HBM Healthcare Investments4 shared
Deerfield4 shared
Last updated: 7 October 2026